Replies to post #114776 on Biotech Values

[ronpopeil]

yes, but i think the terms are favorable for such a small company. slxp must see something special with this drug to give them such strong upfront payments. i read somewhere it's a $1 billion+ drug. either way, imo, the company is very undervalued. it has $4 in cash and a solid pipeline. i think tudor investment corp, a hedge fund company owns shares. i hear they are a big player. what are your thoughts about the company? undervalued? tia